期刊文献+

可溶性CD40L在冠心病患者血清中的检测意义 被引量:4

Serum Soluble CD40L Level and its Application in Coronary Heart Disease
下载PDF
导出
摘要 目的观察不同类型冠心病患者血清中可溶性CD40配体(sCD40L)变化,并探讨其水平与急性冠脉综合征的斑块稳定性是否有关以及与血脂各组分及冠脉狭窄程度的关系.方法采用酶联免疫吸附法测定64例冠心病患者(急性心肌梗死组18例,不稳定型心绞痛组19例,稳定型心绞痛组27例)及20名正常对照者血清sCD40L浓度.29例冠心病患者冠脉狭窄程度的造影结果.结果急性冠脉综合征患者sCD40L水平〔急性心肌梗死组和不稳定心绞痛组分别为(19.8±3.0)、(19.6±4.3)ng/mL〕,显著高于稳定型心绞痛〔(8.3±3.2)ng/mL,P<0.05〕和正常对照组〔(2.6±1.9)ng/mL,P<0.05〕,而在稳定型心绞痛组与正常组间差异无显著性;sCD40L水平与高密度脂蛋白胆固醇呈负相关(r=?0.301,P<0.05),与冠脉狭窄程度呈正比(r=0.48,P<0.01).结论急性冠脉综合征患者外周血sCD40L水平明显升高,这可能与急性冠脉综合征的发生有关,且可作为动脉粥样硬化斑块不稳定的一个重要标志.冠脉狭窄严重程度与sCD40L水平成正比,抑制sCD40L水平有望成为治疗再狭窄的重要方法. Objective To investigate the serum of soluble CD40 ligand (sCD40L) in coronary heart disease and its relationship with serum lipid levels and the extent of coronary stenosis, whether upregulation of CD40L system is related to stability of atherosclerotic plaque in patients with acute coronary syndrome. Methods Enzyme - linked immunosorbent assay (ELISA) was used to measure the level of sCD40L in 64 patients with coronary heart disease ( 18 with acute myocardial infarction, 19 with unstable angina pectoris and the other 27 with stable angina peetoris ) and 20 matched heahhy controls. Coronary stenosis of 29 patients were assessed by angiographic coronary stenosis morphology. Results sCD40L level was significantly higher in patients with acute coronary syndrome (ACS) [ ( 19.8±3.0 ), ( 19.6 ± 4. 3 ) ng/mL in acute myocardial infarction and unstable angina pectoris group, respectively ] than that of those with stable coronary heart disease and that of controis [ ( 8.3 ±3.2 ) ng/mL and (2.6 ± 1.9 ) ng/mL, respectively P 〈 0. 05 ] . Serum sCD40L level was neg- atively related to HDL-C ( r = -0. 301, P 〈0. 05), and positively related to coronary stenosis ( r =0.48, P 〈0.01 ) . Conclution The levels of sCD40L increase in acute coronary syndrome, which may be related to the pathogenesis of ACS, and can be used as a potential marker of plaque instability, which is positively to the extent of coronary stenosis, inhibitor of CD40L can be used as a important method to heal restenosis,
出处 《昆明医学院学报》 2006年第1期30-34,共5页 Journal of Kunming Medical College
关键词 可溶性 CD40配体 冠心病 动脉粥样硬化 心绞痛 Soluble CD40 ligand Coronary heart disease Atherosclerosis Angina pectoris
  • 相关文献

参考文献13

  • 1ROSS R.Atherosclerosis -an inflammatory disease[J].NEngJMed,1999,340 (2):115-126.
  • 2KARPUSAS M,HSU Y M,WANG J H,et al.2A crystal structure of an extracellular fragment of human CD40 ligand[J].Structure,1995,3:1426.
  • 3BRUEMMER D,RIGGERS U,HOLZMEISTER J,et al.Expression of CD40 in vascular smooth muscle cells and macrophages is associated with early development of human atherosclerotic lesion[J].Am J Cardiol,2001,87:21-27.
  • 4HAKKINEN T,KARKOLA K,YLA-HERTTUALA S,et al.Macrophages,smooth muscle cells,endothelial cells,and T-cells express CD40 and CD40L in fatty streaks and more advanced human atherosclerotic lesions,colocalization with epitopes of oxidized lovdensity lipoprotein,scavenger receptor,and CD16(Fc gamma RⅢ)[J].Virchows Arch,2000,437:396-405.
  • 5MACH F,SCHONBECK U,SUKHOVA G K,et al.Functional CD40 ligand is expressed on human vascular endothelial cells,smooth muscle cells,and macrophages:implications for CD40-CD40 ligand signaling in atherosclerosis[J].Proc Natl Acad Sci USA,1997,94:1931 -1936.
  • 6GENSINI G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51 (3):606.
  • 7FALK E,SHAH P K,FUSTER V.Coronary plaque disruption[J].Circulation,1995,92 (6):657-671.
  • 8LEEY,LEEWH,LEE S C,et al.CD40Lactivation in circulating platelets in patients with acute coronary syndrome[J].Cardiology,1999,92 (1):11 -16.
  • 9AUKRUST P,MULLER F,UELAND T,et al.Enhanced levels of soluble and membrane-bound CD40ligand in patients with unstable angina-possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndrome[J].Circulation,1999,106:614-620.
  • 10严金川,吴宗贵,张玲珍,李莉,仲人前,孔宪涛.CD40配体高表达与不稳定型心绞痛之间的关系[J].中国动脉硬化杂志,2001,9(5):409-412. 被引量:16

二级参考文献2

共引文献15

同被引文献30

  • 1李美华,刘征,孙忠人,魏钧.心痹贴辅助治疗冠心病心绞痛42例临床研究[J].中医药信息,2008,25(1):60-62. 被引量:7
  • 2冯润芬,罗陆一.通心贴心俞穴外敷治疗冠心病心绞痛60例临床观察[J].中国中医药科技,2005,12(1):47-48. 被引量:13
  • 3Shah PK. Mechanism of plaque vulnerability and rupture [J]. J Am Coll Cardiol,2003,41(Suppl 1): 15-22.
  • 4Inwald DP, McDowall A,Peters MJ,et al. CD40 is constutively expressed on platelets and provides a novel mechanism for platelet activafion[J]. Circ Res, 2003,92: 1041- 1048.
  • 5Fussl RT,Kranenberg E,Kiausch U, et al. Vascular remodeling in atherosclerotic coronary arteries is affected by plaque composition[J]. Coron Artery Dis, 2001,12: 91-97:6930-6932.
  • 6Hassan A, Basisht R, Nakamura M, et al, Morphological characteristics of de novo coronary lesions presenting with plaque ruptute an intravascular ultrasound study[J]. J Am Coll Cardiol,2004,43:73.
  • 7GA Rodriguez-Granillo, P W Serruys, H M Garcia- Garcia, et al. Coronary arteryremodelling is related to plaque composition[J]. Heart , 2006, 92 (1) : 399- 391.
  • 8Ehrin J. Armstrong, David. Morrow, Marc S. Sabatone Inflammatory Biomarkers in Acute Coronary Syndromes: Pater Ⅰ: Introduction and Cytokinse[J]. Circulation, 2006, 113:72-75.
  • 9Phipps RP. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system [J]. Proc Natl Acad Sci USA,2000,97:6930-6932.
  • 10Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice[J]. Proc Natl Acad Sci US A, 2000,97: 7458-7436.

引证文献4

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部